Motion Sickness Treatment Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2000
N/A
CAGR (2019-2027)
N/A
Market Size
327
Report Pages
135
Market Tables
Overview
Global Motion Sickness Treatment Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a XX% CAGR of around XX% during a forecast period.
To know about the Research Methodology :- Request Free Sample Report
The symptoms intricate in motion sickness like nausea, vomiting, dizziness, headache and irritability. Around 75% to 80% population undergoes from motion sickness in travelling. Therefore, considering the frequency and cause of Motion sickness disorder is indicating the growth of Motion Sickness Treatment Market.
The scope of the report includes a detailed study of global and regional markets for Motion Sickness Treatment with the reasons given for variants in the growth of the industry in certain regions.The development of obesity-related disorders like diabetes, cardiovascular diseases and others have substantially increased in last two years, and these are responsible for growth of motion sickness treatment market. However, introduction of generic transdermal scopolamine patches in the U.S. and availability of other such products in Asia Pacific are feasible to hamper the motion sickness treatment market. Further, the motion sickness treatment market is segmented with availability of enormous number of OTC products across the globe. Nevertheless, increase in disposable income and rise in number of domestic and international travelers are estimated to drive the motion sickness treatment market in forecast period.
The report on Motion Sickness Treatment market covers segments such as Treatment Type, Route of Administration, Distribution Channel and Region. The Treatment Type segment includes Anticholinergic, Antihistamines Sympathomimetic, Traditional Medicines and Others. Among the Treatment Type, Antihistamines Sympathomimetic is accounted for the largest XX% market share in the Motion Sickness Treatment market.
The Route of Administration segment is further sub-segmented into Oral, Transdermal, Parenteral and Other. Among the Route of Administration, Oral route of administration is accounted for the largest XX% market share in the Motion Sickness Treatment market. Based on Distribution Channel, the Motion Sickness Treatment market is sub-segmented into Retail Pharmacies, Online Pharmacies, Drug Stores and Others. Amongst them Retail Pharmacies are accounted for the largest XX% market share in the global Motion Sickness Treatment market.
Based on regional segment, the global Motion Sickness Treatment market is sub-segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America was dominating market for Motion Sickness Treatment Market in 2018. Increased acceptance of recommendation of motion sickness drugs in the U.S. is a key factor for griping the large share of the region. Europe holds second position in the Motion Sickness Treatment Market. Increase in number of travelers is expected to grow the Motion Sickness Treatment Market in Europe. Asia Pacific is witnessed as the developing motion sickness treatment market in recent few years. Rise in disposable income and increase in number of domestic and international travelers are expected to boost the motion sickness treatment market in Asia Pacific.
Key players operating in the Motion Sickness Treatment market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Brands Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc., Myungmoon Pharm Co. Ltd., Baxter International Inc., Reliefband Technologies LLC., and CVS Health.
Most of these key players are emphasize on brand enlargement over the promotion of new product or drug alternates. Nevertheless, there are several small and mid-sized OTC product suppliers functioning in the international and regional markets. For example, the first generic to transdermal scopolamine patch was hosted in the U.S. in 2017, although regional players are introducing their transdermal scopolamine systems in Asia Pacific since 2000. These factors are responsible for growth of motion sickness treatment market across the globe.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global Motion Sickness Treatment market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the global Motion Sickness Treatment market.
Scope of the Global Motion Sickness Treatment Marketl: Inquire before buying
Global Motion Sickness Treatment Market, By Treatment Type
• Anticholinergic
• Antihistamines Sympathomimetic
• Traditional Medicines
• Others
Global Motion Sickness Treatment Market, By Route of Administration
• Oral
• Transdermal
• Parenteral
• Other
Global Motion Sickness Treatment Market, By Distribution Channel
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• Others
Global Motion Sickness Treatment Market, By Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America
Key players operating in the Global Motion Sickness Treatment Market
• GlaxoSmithKline plc.
• Perrigo Company plc.
• Prestige Brands Inc.
• WellSpring Pharmaceutical Corporation
• Caleb Pharmaceuticals Inc.
• Myungmoon Pharm Co. Ltd.
• Baxter International Inc.
• Reliefband Technologies LLC.
• CVS Health
Table of Contents
Global Motion Sickness Treatment Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Motion Sickness Treatment Market Size, by Market Value (US$ Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Motion Sickness Treatment Market Analysis and Forecast
6.1. Global Motion Sickness Treatment Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Motion Sickness Treatment Market Analysis and Forecast, By Treatment Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Motion Sickness Treatment Market Value Share Analysis, By Treatment Type
7.4. Global Motion Sickness Treatment Market Size (US$ Bn) Forecast, By Treatment Type
7.5. Global Motion Sickness Treatment Market Analysis, By Treatment Type
7.6. Global Motion Sickness Treatment Market Attractiveness Analysis, By Treatment Type
8. Motion Sickness Treatment Market Analysis and Forecast, By Route of Administration
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Motion Sickness Treatment Market Value Share Analysis, By Route of Administration
8.4. Global Motion Sickness Treatment Market Size (US$ Bn) Forecast, By Route of Administration
8.5. Global Motion Sickness Treatment Market Analysis, By Route of Administration
8.6. Global Motion Sickness Treatment Market Attractiveness Analysis, By Route of Administration
9. Motion Sickness Treatment Market Analysis and Forecast, By Distribution Channel
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel
9.4. Global Motion Sickness Treatment Market Size (US$ Bn) Forecast, By Distribution Channel
9.5. Global Motion Sickness Treatment Market Analysis, By Distribution Channel
9.6. Global Motion Sickness Treatment Market Attractiveness Analysis, By Distribution Channel
10. Motion Sickness Treatment Market Analysis, by Region
10.1. Global Motion Sickness Treatment Market Value Share Analysis, by Region
10.2. Global Motion Sickness Treatment Market Size (US$ Bn) Forecast, by Region
10.3. Global Motion Sickness Treatment Market Attractiveness Analysis, by Region
11. North America Motion Sickness Treatment Market Analysis
11.1. Key Findings
11.2. North America Motion Sickness Treatment Market Overview
11.3. North America Motion Sickness Treatment Market Value Share Analysis, By Treatment Type
11.4. North America Motion Sickness Treatment Market Forecast, By Treatment Type
11.4.1. Anticholinergic
11.4.2. Antihistamines Sympathomimetic
11.4.3. Traditional Medicines
11.4.4. Others
11.5. North America Motion Sickness Treatment Market Value Share Analysis, By Route of Administration
11.6. North America Motion Sickness Treatment Market Forecast, By Route of Administration
11.6.1. Oral
11.6.2. Transdermal
11.6.3. Parenteral
11.6.4. Other
11.7. North America Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel
11.8. North America Motion Sickness Treatment Market Forecast, By Distribution Channel
11.8.1. Retail Pharmacies
11.8.2. Online Pharmacies
11.8.3. Drug Stores
11.8.4. Others
11.9. North America Motion Sickness Treatment Market Value Share Analysis, by Country
11.10. North America Motion Sickness Treatment Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Motion Sickness Treatment Market Analysis, by Country
11.12. U.S. Motion Sickness Treatment Market Forecast, By Treatment Type
11.12.1. Anticholinergic
11.12.2. Antihistamines Sympathomimetic
11.12.3. Traditional Medicines
11.12.4. Others
11.13. U.S. Motion Sickness Treatment Market Forecast, By Route of Administration
11.13.1. Oral
11.13.2. Transdermal
11.13.3. Parenteral
11.13.4. Other
11.14. U.S. Motion Sickness Treatment Market Forecast, By Distribution Channel
11.14.1. Retail Pharmacies
11.14.2. Online Pharmacies
11.14.3. Drug Stores
11.14.4. Others
11.15. Canada Motion Sickness Treatment Market Forecast, By Treatment Type
11.15.1. Anticholinergic
11.15.2. Antihistamines Sympathomimetic
11.15.3. Traditional Medicines
11.15.4. Others
11.16. Canada Motion Sickness Treatment Market Forecast, By Route of Administration
11.16.1. Oral
11.16.2. Transdermal
11.16.3. Parenteral
11.16.4. Other
11.17. Canada Motion Sickness Treatment Market Forecast, By Distribution Channel
11.17.1. Retail Pharmacies
11.17.2. Online Pharmacies
11.17.3. Drug Stores
11.17.4. Others
11.18. North America Motion Sickness Treatment Market Attractiveness Analysis
11.18.1. By Treatment Type
11.18.2. By Route of Administration
11.18.3. By Distribution Channel
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments
12. Europe Motion Sickness Treatment Market Analysis
12.1. Key Findings
12.2. Europe Motion Sickness Treatment Market Overview
12.3. Europe Motion Sickness Treatment Market Value Share Analysis, By Treatment Type
12.4. Europe Motion Sickness Treatment Market Forecast, By Treatment Type
12.4.1. Anticholinergic
12.4.2. Antihistamines Sympathomimetic
12.4.3. Traditional Medicines
12.4.4. Others
12.5. Europe Motion Sickness Treatment Market Value Share Analysis, By Route of Administration
12.6. Europe Motion Sickness Treatment Market Forecast, By Route of Administration
12.6.1. Oral
12.6.2. Transdermal
12.6.3. Parenteral
12.6.4. Other
12.7. Europe Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel
12.8. Europe Motion Sickness Treatment Market Forecast, By Distribution Channel
12.8.1. Retail Pharmacies
12.8.2. Online Pharmacies
12.8.3. Drug Stores
12.8.4. Others
12.9. Europe Motion Sickness Treatment Market Value Share Analysis, by Country
12.10. Europe Motion Sickness Treatment Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Motion Sickness Treatment Market Analysis, by Country
12.12. Germany Motion Sickness Treatment Market Forecast, By Treatment Type
12.12.1. Anticholinergic
12.12.2. Antihistamines Sympathomimetic
12.12.3. Traditional Medicines
12.12.4. Others
12.13. Germany Motion Sickness Treatment Market Forecast, By Route of Administration
12.13.1. Oral
12.13.2. Transdermal
12.13.3. Parenteral
12.13.4. Other
12.14. Germany Motion Sickness Treatment Market Forecast, By Distribution Channel
12.14.1. Retail Pharmacies
12.14.2. Online Pharmacies
12.14.3. Drug Stores
12.14.4. Others
12.15. U.K. Motion Sickness Treatment Market Forecast, By Treatment Type
12.15.1. Anticholinergic
12.15.2. Antihistamines Sympathomimetic
12.15.3. Traditional Medicines
12.15.4. Others
12.16. U.K. Motion Sickness Treatment Market Forecast, By Route of Administration
12.16.1. Oral
12.16.2. Transdermal
12.16.3. Parenteral
12.16.4. Other
12.17. U.K. Motion Sickness Treatment Market Forecast, By Distribution Channel
12.17.1. Retail Pharmacies
12.17.2. Online Pharmacies
12.17.3. Drug Stores
12.17.4. Others
12.18. France Motion Sickness Treatment Market Forecast, By Treatment Type
12.18.1. Anticholinergic
12.18.2. Antihistamines Sympathomimetic
12.18.3. Traditional Medicines
12.18.4. Others
12.19. France Motion Sickness Treatment Market Forecast, By Route of Administration
12.19.1. Oral
12.19.2. Transdermal
12.19.3. Parenteral
12.19.4. Other
12.20. France Motion Sickness Treatment Market Forecast, By Distribution Channel
12.20.1. Retail Pharmacies
12.20.2. Online Pharmacies
12.20.3. Drug Stores
12.20.4. Others
12.21. Italy Motion Sickness Treatment Market Forecast, By Treatment Type
12.21.1. Anticholinergic
12.21.2. Antihistamines Sympathomimetic
12.21.3. Traditional Medicines
12.21.4. Others
12.22. Italy Motion Sickness Treatment Market Forecast, By Route of Administration
12.22.1. Oral
12.22.2. Transdermal
12.22.3. Parenteral
12.22.4. Other
12.23. Italy Motion Sickness Treatment Market Forecast, By Distribution Channel
12.23.1. Retail Pharmacies
12.23.2. Online Pharmacies
12.23.3. Drug Stores
12.23.4. Others
12.24. Spain Motion Sickness Treatment Market Forecast, By Treatment Type
12.24.1. Anticholinergic
12.24.2. Antihistamines Sympathomimetic
12.24.3. Traditional Medicines
12.24.4. Others
12.25. Spain Motion Sickness Treatment Market Forecast, By Route of Administration
12.25.1. Oral
12.25.2. Transdermal
12.25.3. Parenteral
12.25.4. Other
12.26. Spain Motion Sickness Treatment Market Forecast, By Distribution Channel
12.26.1. Retail Pharmacies
12.26.2. Online Pharmacies
12.26.3. Drug Stores
12.26.4. Others
12.27. Rest of Europe Motion Sickness Treatment Market Forecast, By Treatment Type
12.27.1. Anticholinergic
12.27.2. Antihistamines Sympathomimetic
12.27.3. Traditional Medicines
12.27.4. Others
12.28. Rest of Europe Motion Sickness Treatment Market Forecast, By Route of Administration
12.28.1. Oral
12.28.2. Transdermal
12.28.3. Parenteral
12.28.4. Other
12.29. Rest of Europe Motion Sickness Treatment Market Forecast, By Distribution Channel
12.29.1. Retail Pharmacies
12.29.2. Online Pharmacies
12.29.3. Drug Stores
12.29.4. Others
12.30. Europe Motion Sickness Treatment Market Attractiveness Analysis
12.30.1. By Treatment Type
12.30.2. By Route of Administration
12.30.3. By Distribution Channel
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments
13. Asia Pacific Motion Sickness Treatment Market Analysis
13.1. Key Findings
13.2. Asia Pacific Motion Sickness Treatment Market Overview
13.3. Asia Pacific Motion Sickness Treatment Market Value Share Analysis, By Treatment Type
13.4. Asia Pacific Motion Sickness Treatment Market Forecast, By Treatment Type
13.4.1. Anticholinergic
13.4.2. Antihistamines Sympathomimetic
13.4.3. Traditional Medicines
13.4.4. Others
13.5. Asia Pacific Motion Sickness Treatment Market Value Share Analysis, By Route of Administration
13.6. Asia Pacific Motion Sickness Treatment Market Forecast, By Route of Administration
13.6.1. Oral
13.6.2. Transdermal
13.6.3. Parenteral
13.6.4. Other
13.7. Asia Pacific Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel
13.8. Asia Pacific Motion Sickness Treatment Market Forecast, By Distribution Channel
13.8.1. Retail Pharmacies
13.8.2. Online Pharmacies
13.8.3. Drug Stores
13.8.4. Others
13.9. Asia Pacific Motion Sickness Treatment Market Value Share Analysis, by Country
13.10. Asia Pacific Motion Sickness Treatment Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Motion Sickness Treatment Market Analysis, by Country
13.12. China Motion Sickness Treatment Market Forecast, By Treatment Type
13.12.1. Anticholinergic
13.12.2. Antihistamines Sympathomimetic
13.12.3. Traditional Medicines
13.12.4. Others
13.13. China Motion Sickness Treatment Market Forecast, By Route of Administration
13.13.1. Oral
13.13.2. Transdermal
13.13.3. Parenteral
13.13.4. Other
13.14. China Motion Sickness Treatment Market Forecast, By Distribution Channel
13.14.1. Retail Pharmacies
13.14.2. Online Pharmacies
13.14.3. Drug Stores
13.14.4. Others
13.15. India Motion Sickness Treatment Market Forecast, By Treatment Type
13.15.1. Anticholinergic
13.15.2. Antihistamines Sympathomimetic
13.15.3. Traditional Medicines
13.15.4. Others
13.16. India Motion Sickness Treatment Market Forecast, By Route of Administration
13.16.1. Oral
13.16.2. Transdermal
13.16.3. Parenteral
13.16.4. Other
13.17. India Motion Sickness Treatment Market Forecast, By Distribution Channel
13.17.1. Retail Pharmacies
13.17.2. Online Pharmacies
13.17.3. Drug Stores
13.17.4. Others
13.18. Japan Motion Sickness Treatment Market Forecast, By Treatment Type
13.18.1. Anticholinergic
13.18.2. Antihistamines Sympathomimetic
13.18.3. Traditional Medicines
13.18.4. Others
13.19. Japan Motion Sickness Treatment Market Forecast, By Route of Administration
13.19.1. Oral
13.19.2. Transdermal
13.19.3. Parenteral
13.19.4. Other
13.20. Japan Motion Sickness Treatment Market Forecast, By Distribution Channel
13.20.1. Retail Pharmacies
13.20.2. Online Pharmacies
13.20.3. Drug Stores
13.20.4. Others
13.21. ASEAN Motion Sickness Treatment Market Forecast, By Treatment Type
13.21.1. Anticholinergic
13.21.2. Antihistamines Sympathomimetic
13.21.3. Traditional Medicines
13.21.4. Others
13.22. ASEAN Motion Sickness Treatment Market Forecast, By Route of Administration
13.22.1. Oral
13.22.2. Transdermal
13.22.3. Parenteral
13.22.4. Other
13.23. ASEAN Motion Sickness Treatment Market Forecast, By Distribution Channel
13.23.1. Retail Pharmacies
13.23.2. Online Pharmacies
13.23.3. Drug Stores
13.23.4. Others
13.24. Rest of Asia Pacific Motion Sickness Treatment Market Forecast, By Treatment Type
13.24.1. Anticholinergic
13.24.2. Antihistamines Sympathomimetic
13.24.3. Traditional Medicines
13.24.4. Others
13.25. Rest of Asia Pacific Motion Sickness Treatment Market Forecast, By Route of Administration
13.25.1. Oral
13.25.2. Transdermal
13.25.3. Parenteral
13.25.4. Other
13.26. Rest of Asia Pacific Motion Sickness Treatment Market Forecast, By Distribution Channel
13.26.1. Retail Pharmacies
13.26.2. Online Pharmacies
13.26.3. Drug Stores
13.26.4. Others
13.27. Asia Pacific Motion Sickness Treatment Market Attractiveness Analysis
13.27.1. By Treatment Type
13.27.2. By Route of Administration
13.27.3. By Distribution Channel
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments
14. Middle East & Africa Motion Sickness Treatment Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Motion Sickness Treatment Market Overview
14.3. Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, By Treatment Type
14.4. Middle East & Africa Motion Sickness Treatment Market Forecast, By Treatment Type
14.4.1. Anticholinergic
14.4.2. Antihistamines Sympathomimetic
14.4.3. Traditional Medicines
14.4.4. Others
14.5. Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, By Route of Administration
14.6. Middle East & Africa Motion Sickness Treatment Market Forecast, By Route of Administration
14.6.1. Oral
14.6.2. Transdermal
14.6.3. Parenteral
14.7. Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel
14.8. Middle East & Africa Motion Sickness Treatment Market Forecast, By Distribution Channel
14.8.1. Retail Pharmacies
14.8.2. Online Pharmacies
14.8.3. Drug Stores
14.8.4. Others
14.9. Middle East & Africa Motion Sickness Treatment Market Value Share Analysis, by Country
14.10. Middle East & Africa Motion Sickness Treatment Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Motion Sickness Treatment Market Analysis, by Country
14.12. GCC Motion Sickness Treatment Market Forecast, By Treatment Type
14.12.1. Anticholinergic
14.12.2. Antihistamines Sympathomimetic
14.12.3. Traditional Medicines
14.12.4. Others
14.13. GCC Motion Sickness Treatment Market Forecast, By Route of Administration
14.13.1. Oral
14.13.2. Transdermal
14.13.3. Parenteral
14.13.4. Other
14.14. GCC Motion Sickness Treatment Market Forecast, By Distribution Channel
14.14.1. Retail Pharmacies
14.14.2. Online Pharmacies
14.14.3. Drug Stores
14.14.4. Others
14.15. South Africa Motion Sickness Treatment Market Forecast, By Route of Administration
14.15.1. Oral
14.15.2. Transdermal
14.15.3. Parenteral
14.15.4. Other
14.16. South Africa Motion Sickness Treatment Market Forecast, By Distribution Channel
14.16.1. Retail Pharmacies
14.16.2. Online Pharmacies
14.16.3. Drug Stores
14.16.4. Others
14.17. Rest of Middle East & Africa Motion Sickness Treatment Market Forecast, By Treatment Type
14.17.1. Anticholinergic
14.17.2. Antihistamines Sympathomimetic
14.17.3. Traditional Medicines
14.17.4. Others
14.18. Rest of Middle East & Africa Motion Sickness Treatment Market Forecast, By Route of Administration
14.18.1. Oral
14.18.2. Transdermal
14.18.3. Parenteral
14.18.4. Other
14.19. Rest of Middle East & Africa Motion Sickness Treatment Market Forecast, By Distribution Channel
14.19.1. Retail Pharmacies
14.19.2. Online Pharmacies
14.19.3. Drug Stores
14.19.4. Others
14.20. Middle East & Africa Motion Sickness Treatment Market Attractiveness Analysis
14.20.1. By Treatment Type
14.20.2. By Route of Administration
14.20.3. By Distribution Channel
14.21. PEST Analysis
14.22. Key Trends
14.23. Key Developments
15. South America Motion Sickness Treatment Market Analysis
15.1. Key Findings
15.2. South America Motion Sickness Treatment Market Overview
15.3. South America Motion Sickness Treatment Market Value Share Analysis, By Treatment Type
15.4. South America Motion Sickness Treatment Market Forecast, By Treatment Type
15.4.1. Anticholinergic
15.4.2. Antihistamines Sympathomimetic
15.4.3. Traditional Medicines
15.4.4. Others
15.5. South America Motion Sickness Treatment Market Value Share Analysis, By Route of Administration
15.6. South America Motion Sickness Treatment Market Forecast, By Route of Administration
15.6.1. Oral
15.6.2. Transdermal
15.6.3. Parenteral
15.6.4. Other
15.7. South America Motion Sickness Treatment Market Value Share Analysis, By Distribution Channel
15.8. South America Motion Sickness Treatment Market Forecast, By Distribution Channel
15.8.1. Retail Pharmacies
15.8.2. Online Pharmacies
15.8.3. Drug Stores
15.8.4. Others
15.9. South America Motion Sickness Treatment Market Value Share Analysis, by Country
15.10. South America Motion Sickness Treatment Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Motion Sickness Treatment Market Analysis, by Country
15.12. Brazil Motion Sickness Treatment Market Forecast, By Treatment Type
15.12.1. Anticholinergic
15.12.2. Antihistamines Sympathomimetic
15.12.3. Traditional Medicines
15.12.4. Others
15.13. Brazil Motion Sickness Treatment Market Forecast, By Route of Administration
15.13.1. Oral
15.13.2. Transdermal
15.13.3. Parenteral
15.13.4. Other
15.14. Brazil Motion Sickness Treatment Market Forecast, By Distribution Channel
15.14.1. Retail Pharmacies
15.14.2. Online Pharmacies
15.14.3. Drug Stores
15.14.4. Others
15.15. Mexico Motion Sickness Treatment Market Forecast, By Treatment Type
15.15.1. Anticholinergic
15.15.2. Antihistamines Sympathomimetic
15.15.3. Traditional Medicines
15.15.4. Others
15.16. Mexico Motion Sickness Treatment Market Forecast, By Route of Administration
15.16.1. Oral
15.16.2. Transdermal
15.16.3. Parenteral
15.16.4. Other
15.17. Mexico Motion Sickness Treatment Market Forecast, By Distribution Channel
15.17.1. Retail Pharmacies
15.17.2. Online Pharmacies
15.17.3. Drug Stores
15.17.4. Others
15.18. Rest of South America Motion Sickness Treatment Market Forecast, By Treatment Type
15.18.1. Anticholinergic
15.18.2. Antihistamines Sympathomimetic
15.18.3. Traditional Medicines
15.18.4. Others
15.19. Rest of South America Motion Sickness Treatment Market Forecast, By Route of Administration
15.19.1. Oral
15.19.2. Transdermal
15.19.3. Parenteral
15.19.4. Other
15.20. Rest of South America Motion Sickness Treatment Market Forecast, By Distribution Channel
15.20.1. Retail Pharmacies
15.20.2. Online Pharmacies
15.20.3. Drug Stores
15.20.4. Others
15.21. South America Motion Sickness Treatment Market Attractiveness Analysis
15.21.1. By Treatment Type
15.21.2. By Route of Administration
15.21.3. By Distribution Channel
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments
16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Route of Administrations and R&D investment
16.2.2. New Treatment Center Launches and Treatment Center Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Route of Administrations
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. GlaxoSmithKline plc.
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Treatment Center Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Company Footprint
16.3.2. Perrigo Company plc.
16.3.3. Prestige Brands Inc.
16.3.4. WellSpring Pharmaceutical Corporation
16.3.5. Caleb Pharmaceuticals Inc.
16.3.6. Myungmoon Pharm Co. Ltd.
16.3.7. Baxter International Inc.
16.3.8. Reliefband Technologies LLC.
16.3.9. CVS Health.
17. Primary Key Insights